- Home
- LNTH vs DNP Comparison
LNTH vs DNP Comparison
Compare LNTH & DNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LNTH | DNP |
|---|---|---|
| Founded | 1956 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.8B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | LNTH | DNP |
|---|---|---|
| Price | $67.59 | $10.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $78.00 | N/A |
| AVG Volume (30 Days) | ★ 788.1K | 479.6K |
| Earning Date | 02-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.88% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.39 | 2.30 |
| Revenue | ★ $1,525,933,000.00 | $154,887,179.00 |
| Revenue This Year | $0.01 | N/A |
| Revenue Next Year | $0.26 | N/A |
| P/E Ratio | $28.21 | ★ $4.26 |
| Revenue Growth | 1.95 | ★ 3.30 |
| 52 Week Low | $47.25 | $8.69 |
| 52 Week High | $111.29 | $10.04 |
Technical Indicators
Market Signals| Indicator | LNTH | DNP |
|---|---|---|
| Relative Strength Index (RSI) | 58.69 | 54.05 |
| Support Level | $63.37 | $9.99 |
| Resistance Level | $67.92 | $10.09 |
| Average True Range (ATR) | 2.06 | 0.09 |
| MACD | -0.37 | 0.02 |
| Stochastic Oscillator | 58.76 | 88.75 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About DNP DNP Select Income Fund Inc.
DNP Select Income Fund Inc is a closed-ended investment management fund. The primary investment objectives of the fund are current income and long-term growth of income. Its secondary objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing in the public utility industry.